The microbiota-derived metabolites can activate TLR2 on glial cells, which results in an increased IL-22 secretion by innate lymphoid cells (ILC)-3 to provide protection against inflammation or pathogenic infection [4]. This evidence concerns the gene TLR2 and infection.